Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

sipuleucel-T

View Patient Information
A cell-based vaccine composed of autologous antigen-presenting peripheral blood mononuclear cells (enriched for a dendritic cell fraction) that have been exposed to a recombinant protein consisting of granulocyte-macrophage colony-stimulating factor (GM-CSF) fused to prostatic-acid phosphatase (PAP), a protein expressed by prostate cancer cells. Upon administration, the vaccine may stimulate an antitumor T-cell response against tumor cells expressing PAP.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:APC8015 vaccine
PA2024 (PAP/GM-CSF)-loaded dendritic cell vaccine
SipT
US brand name:Provenge
Code name:APC 8015
APC8015
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search